Discover the ground-breaking digital algorithms allowing pathologists to more accurately assess biomarkers with potential to improve therapy selection and patient outcomes.
Peter Mac's Dr Cameron Snell will share his experience evaluating an algorithm to assess HER2 in situ hybridisation, aiming to reduce interobserver variability in challenging HER2 ISH cases. He will also explore the potential for digital algorithms to enhance care for patients with low levels of ER expression and enumerate proliferation by ki-67.
In this session, you will:
Don't miss this opportunity to learn about the cutting-edge applications of digital algorithms in breast cancer management!
Dr Cameron Snell is the Head of Anatomical Pathology at Peter MacCallum Cancer Centre. He has a keen interest in breast cancer biomarkers and digital image analysis. Dr Snell is also actively involved in quality and policy, serving on the Board of Professional Practice and Quality for the RCPA, as a NATA assessor, and as an expert reviewer for the RCPA Quality Assurance Program. He holds honorary affiliations with the University of Queensland and QUT.
